C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy

[1]  E. Antman,et al.  Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy. , 1998, Journal of the American College of Cardiology.

[2]  L. Wallentin,et al.  Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group. , 1997, European heart journal.

[3]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[4]  S. Thompson,et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.

[5]  L. Kuller,et al.  Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.

[6]  G. Ciliberto,et al.  Elevated levels of interleukin-6 in unstable angina. , 1996, Circulation.

[7]  L. Wallentin,et al.  Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. , 1996, Circulation.

[8]  D. Strachan,et al.  C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.

[9]  A. Maseri,et al.  Inflammation in ischaemic heart disease , 1996, BMJ.

[10]  V. Gökhan Cin,et al.  The prognostic value of serum troponin T in unstable angina. , 1996, International journal of cardiology.

[11]  A. Remppis,et al.  Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. , 1995, Circulation.

[12]  E. Antman,et al.  Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. , 1995, JAMA.

[13]  S. Thompson,et al.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.

[14]  G. Assmann,et al.  Association of Variables of Coagulation, Fibrinolysis and Acute-phase with Atherosclerosis in Coronary and Peripheral Arteries and those Arteries Supplying the Brain , 1995, Thrombosis and Haemostasis.

[15]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[16]  Alexander Rw.  Inflammation and Coronary Artery Disease , 1994 .

[17]  L. Wilkins.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.

[18]  T. Sakamoto,et al.  Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. , 1993, American heart journal.

[19]  F. Van de Werf,et al.  Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. , 1993, European heart journal.

[20]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[21]  M. Pepys,et al.  Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. , 1993, The Journal of clinical investigation.

[22]  B. Giusti,et al.  Transient Intermittent Lymphocyte Activation Is Responsible for the Instabilit of Angina , 1992, Circulation.

[23]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[24]  W. Weintraub,et al.  Elevation of C-reactive protein in "active" coronary artery disease. , 1990, The American journal of cardiology.

[25]  M. Alessi,et al.  Plasma Plasminogen Activator Inhibitor‐1 in Angina Pectoris: Influence of Plasma Insulin and Acute‐phase Response , 1989, Arteriosclerosis.

[26]  S. Deodhar,et al.  C-reactive protein: the best laboratory indicator available for monitoring disease activity. , 1989, Cleveland Clinic journal of medicine.

[27]  S. Takebayashi,et al.  Increased subendothelial infiltration of the coronary arteries with monocytes/macrophages in patients with unstable angina. Histological data on 14 autopsied patients. , 1987, Atherosclerosis.

[28]  K. Pietilä,et al.  C-reactive protein in subendocardial and transmural myocardial infarcts. , 1986, Clinical chemistry.

[29]  M. Nobuyoshi,et al.  Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. , 1985, Circulation.

[30]  N. Beeching,et al.  Serum levels of acute phase and cardiac proteins after myocardial infarction, surgery, and infection. , 1982, British heart journal.

[31]  A. Maseri,et al.  Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. , 1982, British heart journal.

[32]  M. Pepys,et al.  Solid phase radioimmunoassays for human C-reactive protein. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[33]  D. Karp,et al.  Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. , 1978, The Journal of clinical investigation.

[34]  R. Ross,et al.  The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.

[35]  Ric,et al.  CARDIAC TROPONIN T LEVELS FOR RISK STRATIFICATION IN ACUTE MYOCARDIAL ISCHEMIA , 2000 .

[36]  J. Eisenberg,et al.  Views from funding agencies. Agency for Health Care Policy and Research. , 1998, Medical care.

[37]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[38]  P. Libby,et al.  Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[39]  R. Cotran,et al.  The pathogenesis of atherosclerosis: atherogenesis and inflammation. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[40]  M. Pepys,et al.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. , 1983, Advances in immunology.